SOSV

Proton Intelligence is a Canadian company, founded in 2020 and based in Vancouver, that specializes in biomarker monitoring to assist in managing chronic diseases and improving patient outcomes. The company has developed a wearable continuous potassium monitoring platform aimed at individuals with hyperkalemia, particularly those suffering from chronic kidney disease and other co-morbidities. By providing accurate and real-time potassium measurements through interstitial fluid analysis, Proton Intelligence facilitates critical health monitoring for both clinicians and patients. This technology enables informed decision-making regarding medications, diet, and treatment options, thereby enhancing the management of hyperkalemia and promoting better overall health for affected individuals.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

Bloomlife is a women's health company focused on addressing critical challenges in maternal health through an innovative remote care platform. By integrating connected devices with cloud-based data analytics, Bloomlife enhances access to care and empowers expectant mothers while providing clinicians with essential information to better screen and manage pregnancy complications. The company's prenatal wearable technology is designed to assess fetal health, enabling the identification of potential complications that could lead to serious outcomes such as brain damage or stillbirth. This approach marks a significant departure from traditional methods of managing high-risk pregnancies, which often involve frequent in-person appointments and lengthy referral processes. Bloomlife aims to be a leader in remote maternal care, facilitating timely interventions and support for women, regardless of geographic barriers.

PeakSyncer, a subsidiary of Zhong Xi Group, LLC, specializes in an AI-powered cloud platform designed to optimize energy management for utility companies. The platform leverages artificial intelligence to automate and streamline demand response programs, helping utilities manage peak energy loads more effectively. Key features include real-time reporting, seamless data tracking, integration with existing infrastructure, and synchronization across ERP and CRM systems. PeakSyncer's scalable solution empowers utilities to meet regulatory requirements, create sustainable energy ecosystems, and engage customers in demand response initiatives. The company offers dedicated support and 24/7 monitoring to ensure reliable, user-friendly solutions that adapt to evolving energy grid needs.

OncoPrecision is a company that focuses on improving cancer therapy outcomes by utilizing a patient micro avatar platform. This innovative platform employs single-cell high-throughput biology and machine learning to generate comprehensive patient-derived phenotypic biomarkers. By doing so, it enables oncologists to make informed, data-driven decisions regarding the selection of cancer therapies tailored to individual patients. The approach aims to increase the success rates of cancer treatments by ensuring that the right therapy is matched to the right patient, thus enhancing overall patient care and treatment effectiveness.

Contextere Corporation is an industrial IoT software company founded in 2015 and based in Ottawa, Canada. The company focuses on enhancing human performance through its intelligent personal agent, which provides actionable insights at the last tactical mile of industrial operations. Contextere's software utilizes artificial intelligence and machine learning to extract and structure previously inaccessible maintenance, repair, and operations data. This capability enables clients, including global corporations, to improve productivity, enhance safety, and minimize equipment downtime. By delivering immediate insights, Contextere aids organizations in increasing situational awareness and managing dynamic data environments effectively, ultimately reducing cognitive overload for the workforce.

Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.

Chronus Health, Inc. is a company that specializes in developing a portable diagnostic platform aimed at delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and based in Mountain View, California, the company's innovative system utilizes microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time test results. This capability allows for immediate diagnosis at the point of care, enhancing the efficiency of treatment and significantly improving patient outcomes. By enabling doctors to obtain lab results in minutes, Chronus Health facilitates timely decision-making in clinical settings.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

LightHearted AI specializes in AI-driven remote cardiovascular diagnostics, offering a tool for swift, accurate, and cost-effective detection of heart conditions. Their medical device aims to prevent heart-related deaths by providing healthcare professionals with faster, more precise, and affordable support than existing technologies, thereby enhancing treatment procedures.

Halla is a company that specializes in Taste Intelligence, focusing on delivering personalized grocery experiences through advanced artificial intelligence. Their platform combines food data and human behavior insights to create tailored product recommendations, substitutions, and search functionalities for grocery retailers. By utilizing machine learning models, Halla enables grocers to understand and respond to individual shopper preferences in real-time. The company's suite of products can be integrated into various customer touchpoints, including online cart pages and in-store promotions, enhancing customer engagement and driving sales. This approach not only helps shoppers discover appealing products at optimal moments but also aims to improve overall shopping experiences and increase transaction values.

Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Pulse Industrial, founded in 2017 and based in California, specializes in developing advanced monitoring solutions for industrial plants, particularly focusing on steam systems. The company has created a smart steam trap monitoring device that employs artificial intelligence to detect steam leaks by analyzing vibration and acoustic behavior. This technology, known as QALM, enhances visibility into potential failures, alerting maintenance personnel through low power wide area communication. Additionally, Pulse Industrial is exploring thermal applications utilizing phase change materials, further expanding its innovative offerings in the industrial sector. By enabling remote monitoring of critical components like steam traps, the company aims to improve safety and reduce fuel consumption across various industrial processes.

AuraSense is focused on enhancing neurological assessments through the integration of artificial intelligence and automation. The company has developed a digital touch technology that enables the detection of early signs of limb damage, facilitating remote physical examinations for various diseases. By combining elements of video game technology with practical medical procedures, AuraSense provides neurologists with a data-driven and quantifiable approach to evaluate patients' cognitive and physical health. This innovation allows for accurate performance assessments, leading to personalized treatment plans tailored to individual patient needs, ultimately aiming to improve health outcomes.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.

BiomeSense, Inc. is a company that specializes in developing an integrated platform combining hardware, software, and data analytics to enhance the collection and analysis of microbiome data in clinical research. Founded in 2018 and based in Chicago, Illinois, BiomeSense has created the GutLab, an innovative "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology, along with the MetaBiome time-series analytics platform, provides a comprehensive solution that enables researchers, patients, and consumers to track microbiome changes in real time and understand their impact on health outcomes. By generating and analyzing large-scale, longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, ultimately improving precision medicine and the development of microbiome-based therapeutics and products.

Halla is a company that specializes in Taste Intelligence, focusing on delivering personalized grocery experiences through advanced artificial intelligence. Their platform combines food data and human behavior insights to create tailored product recommendations, substitutions, and search functionalities for grocery retailers. By utilizing machine learning models, Halla enables grocers to understand and respond to individual shopper preferences in real-time. The company's suite of products can be integrated into various customer touchpoints, including online cart pages and in-store promotions, enhancing customer engagement and driving sales. This approach not only helps shoppers discover appealing products at optimal moments but also aims to improve overall shopping experiences and increase transaction values.

Gaia AI is an MIT spinout focused on enhancing forestry management through advanced perception artificial intelligence. By leveraging technology similar to that used in autonomous vehicles, the company processes various data sources, including LiDAR, camera, and satellite imagery, to provide accurate insights into forest conditions. This approach enables landowners, project developers, and investors to assess the carbon stock and timber content of their properties effectively. Gaia AI aims to modernize the forestry industry by reducing complexities in evaluating the multifaceted values of forests, such as carbon sequestration, ecosystem services that support biodiversity, and wildfire risk management. In doing so, the company seeks to position trees as a viable and economically beneficial solution in the fight against climate change.

Untap Health has developed a pathogen monitoring platform focused on enhancing community health by detecting infections before they escalate into outbreaks. The platform analyzes wastewater samples from various sources, including commercial sites, schools, and wastewater treatment facilities, to identify viruses present in sewage. By leveraging high-frequency data, Untap provides early warnings of potential health incidents, facilitating timely interventions. This non-invasive and anonymized approach enables communities to maintain cleanliness and safety, effectively contributing to public health monitoring and management.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

BizBaz specializes in providing financial intelligence solutions tailored for financial institutions, fintech companies, e-commerce platforms, and telecommunications firms across Asia. With teams located in Singapore, Israel, Vietnam, the Philippines, and Malaysia, the company offers a comprehensive range of services that includes risk assessment, alternative credit scoring, fraud detection, eKYC, and financial product aggregation and recommendation systems. These solutions aim to empower businesses by enhancing their ability to engage with unbanked and underserved populations, thereby improving decision-making processes through reliable financial and customer intelligence.

Proton Intelligence is a Canadian company, founded in 2020 and based in Vancouver, that specializes in biomarker monitoring to assist in managing chronic diseases and improving patient outcomes. The company has developed a wearable continuous potassium monitoring platform aimed at individuals with hyperkalemia, particularly those suffering from chronic kidney disease and other co-morbidities. By providing accurate and real-time potassium measurements through interstitial fluid analysis, Proton Intelligence facilitates critical health monitoring for both clinicians and patients. This technology enables informed decision-making regarding medications, diet, and treatment options, thereby enhancing the management of hyperkalemia and promoting better overall health for affected individuals.

RxDiet is a developer of a nutritional guidance platform that leverages artificial intelligence and automation to provide personalized meal solutions and health interventions. The company partners with national food retailers and leading health plans to deliver fresh groceries tailored to individual cultural and lifestyle preferences. This approach not only promotes a balanced diet but also aims to achieve exceptional clinical outcomes and cost savings for users. By integrating "food as medicine" principles, RxDiet addresses the growing demand for effective nutritional support in healthcare.

Simbe Robotics, Inc. is a technology company based in San Francisco, California, specializing in autonomous robotic solutions for the retail industry. Founded in 2014, the company has developed a robotic system named Tally, which autonomously navigates store aisles to conduct shelf audits. Tally captures real-time inventory data, identifying out-of-stock items, low stock levels, misplaced products, and pricing discrepancies. By automating these repetitive and labor-intensive tasks, Simbe Robotics enhances operational efficiency for retail staff, allowing them to focus on customer service and other critical aspects of store management. The robotic system operates safely during regular store hours, effectively integrating into the shopping environment without disrupting customers or employees.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

Gaia AI is an MIT spinout focused on enhancing forestry management through advanced perception artificial intelligence. By leveraging technology similar to that used in autonomous vehicles, the company processes various data sources, including LiDAR, camera, and satellite imagery, to provide accurate insights into forest conditions. This approach enables landowners, project developers, and investors to assess the carbon stock and timber content of their properties effectively. Gaia AI aims to modernize the forestry industry by reducing complexities in evaluating the multifaceted values of forests, such as carbon sequestration, ecosystem services that support biodiversity, and wildfire risk management. In doing so, the company seeks to position trees as a viable and economically beneficial solution in the fight against climate change.

Kalia Health is a biotechnology company based in Chapel Hill, North Carolina, that focuses on enhancing maternal health outcomes. Founded in 2019, the company has developed a home-based early detection test specifically aimed at identifying preeclampsia, a potentially severe pregnancy complication. Their product includes a low-cost and reliable detection strip that allows mothers to self-screen for preeclampsia periodically. This innovation is designed to improve accessibility to early diagnosis, enabling women to seek timely medical care and mitigate the risks associated with this condition. Kalia Health's commitment to safe and affordable maternal health solutions positions it as a valuable contributor to improving health outcomes for expectant mothers.

Tesarakt is a New York City-based company founded in 2022 that specializes in predictive artificial intelligence for brain care. The firm focuses on developing AI technology aimed at predicting neurological disorders prior to disease progression. By leveraging artificial intelligence and machine learning, Tesarakt enhances the predictive capabilities of neuro-diagnosis through an extensive database of conventional MRI scans. This innovative approach enables medical professionals to identify conditions such as Parkinson's disease and Alzheimer's disease before the onset of initial symptoms, thereby improving early intervention and patient outcomes.

Tesarakt is a New York City-based company founded in 2022 that specializes in predictive artificial intelligence for brain care. The firm focuses on developing AI technology aimed at predicting neurological disorders prior to disease progression. By leveraging artificial intelligence and machine learning, Tesarakt enhances the predictive capabilities of neuro-diagnosis through an extensive database of conventional MRI scans. This innovative approach enables medical professionals to identify conditions such as Parkinson's disease and Alzheimer's disease before the onset of initial symptoms, thereby improving early intervention and patient outcomes.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

Kalia Health is a biotechnology company based in Chapel Hill, North Carolina, that focuses on enhancing maternal health outcomes. Founded in 2019, the company has developed a home-based early detection test specifically aimed at identifying preeclampsia, a potentially severe pregnancy complication. Their product includes a low-cost and reliable detection strip that allows mothers to self-screen for preeclampsia periodically. This innovation is designed to improve accessibility to early diagnosis, enabling women to seek timely medical care and mitigate the risks associated with this condition. Kalia Health's commitment to safe and affordable maternal health solutions positions it as a valuable contributor to improving health outcomes for expectant mothers.

Amper Technologies, Inc. is a Chicago-based company founded in 2016 that develops a clip-on device designed to help factory owners and managers analyze power consumption, predict machine downtime, and implement predictive maintenance. The company provides a comprehensive solution that includes both hardware and software, featuring non-invasive sensors, an Internet-connected gateway, and web dashboards. This technology enables plant managers to monitor various machine types, thereby enhancing productivity and overall equipment effectiveness (OEE). Amper's real-time monitoring and analytics tools allow manufacturing teams to identify root causes of issues, optimize operations, and reduce production losses. The solution is user-friendly and can be deployed quickly across different machines, empowering operators and managers with actionable data to improve performance and meet production targets.

PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

Chronus Health, Inc. is a company that specializes in developing a portable diagnostic platform aimed at delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and based in Mountain View, California, the company's innovative system utilizes microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time test results. This capability allows for immediate diagnosis at the point of care, enhancing the efficiency of treatment and significantly improving patient outcomes. By enabling doctors to obtain lab results in minutes, Chronus Health facilitates timely decision-making in clinical settings.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

Rosetta, Inc. operates as a SaaS platform that assists e-commerce sites in analyzing consumer preferences and enhancing customer retention. Founded in 2018 and based in Taipei, Taiwan, the company leverages deep learning technology to uncover individual consumer behaviors and predict future sales. By focusing on the fashion industry, including apparel, cosmetics, and accessories, Rosetta.ai develops specialized algorithms to cater to the distinct shopping preferences within this vertical. The platform provides personalized recommendations and tools designed to trigger consumer engagement, thereby helping e-commerce businesses improve conversion rates and increase order value, both online and offline.

Proton Intelligence is a Canadian company, founded in 2020 and based in Vancouver, that specializes in biomarker monitoring to assist in managing chronic diseases and improving patient outcomes. The company has developed a wearable continuous potassium monitoring platform aimed at individuals with hyperkalemia, particularly those suffering from chronic kidney disease and other co-morbidities. By providing accurate and real-time potassium measurements through interstitial fluid analysis, Proton Intelligence facilitates critical health monitoring for both clinicians and patients. This technology enables informed decision-making regarding medications, diet, and treatment options, thereby enhancing the management of hyperkalemia and promoting better overall health for affected individuals.

Proton Intelligence is a Canadian company, founded in 2020 and based in Vancouver, that specializes in biomarker monitoring to assist in managing chronic diseases and improving patient outcomes. The company has developed a wearable continuous potassium monitoring platform aimed at individuals with hyperkalemia, particularly those suffering from chronic kidney disease and other co-morbidities. By providing accurate and real-time potassium measurements through interstitial fluid analysis, Proton Intelligence facilitates critical health monitoring for both clinicians and patients. This technology enables informed decision-making regarding medications, diet, and treatment options, thereby enhancing the management of hyperkalemia and promoting better overall health for affected individuals.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Circadia Health specializes in developing AI-powered, FDA-approved contactless patient monitoring systems aimed at enhancing clinical outcomes. The technology enables the detection of respiratory complications from up to eight feet away, eliminating the need for physical devices on the patient or bed. By continuously monitoring respiratory rates, Circadia's system allows clinicians to predict medical events such as congestive heart failure, pneumonia, and sepsis, often hours or days in advance. A team of virtual nurses analyzes device data in conjunction with patients' electronic health records to provide personalized, predictive risk alerts around the clock. This innovative approach not only facilitates remote assessments but also aims to reduce healthcare costs while improving patient care across various settings, from hospitals to home environments.

Lucidefi is focused on enhancing profitability in decentralized finance (DeFi) markets through its innovative trading terminal designed for intelligent investing. The platform offers users a continuously updated selection of investment products, supported by a proprietary time-series predictive analytics engine. This technology enables efficient data provision and execution automation, allowing users to make informed investment decisions with speed and accuracy. Lucidefi aims to simplify the investment process in DeFi by providing comprehensive data and trend analysis, ensuring that users can invest effectively and capitalize on market opportunities when they arise.

Untap Health has developed a pathogen monitoring platform focused on enhancing community health by detecting infections before they escalate into outbreaks. The platform analyzes wastewater samples from various sources, including commercial sites, schools, and wastewater treatment facilities, to identify viruses present in sewage. By leveraging high-frequency data, Untap provides early warnings of potential health incidents, facilitating timely interventions. This non-invasive and anonymized approach enables communities to maintain cleanliness and safety, effectively contributing to public health monitoring and management.

Halla is a company that specializes in Taste Intelligence, focusing on delivering personalized grocery experiences through advanced artificial intelligence. Their platform combines food data and human behavior insights to create tailored product recommendations, substitutions, and search functionalities for grocery retailers. By utilizing machine learning models, Halla enables grocers to understand and respond to individual shopper preferences in real-time. The company's suite of products can be integrated into various customer touchpoints, including online cart pages and in-store promotions, enhancing customer engagement and driving sales. This approach not only helps shoppers discover appealing products at optimal moments but also aims to improve overall shopping experiences and increase transaction values.

BizBaz specializes in providing financial intelligence solutions tailored for financial institutions, fintech companies, e-commerce platforms, and telecommunications firms across Asia. With teams located in Singapore, Israel, Vietnam, the Philippines, and Malaysia, the company offers a comprehensive range of services that includes risk assessment, alternative credit scoring, fraud detection, eKYC, and financial product aggregation and recommendation systems. These solutions aim to empower businesses by enhancing their ability to engage with unbanked and underserved populations, thereby improving decision-making processes through reliable financial and customer intelligence.

BizBaz specializes in providing financial intelligence solutions tailored for financial institutions, fintech companies, e-commerce platforms, and telecommunications firms across Asia. With teams located in Singapore, Israel, Vietnam, the Philippines, and Malaysia, the company offers a comprehensive range of services that includes risk assessment, alternative credit scoring, fraud detection, eKYC, and financial product aggregation and recommendation systems. These solutions aim to empower businesses by enhancing their ability to engage with unbanked and underserved populations, thereby improving decision-making processes through reliable financial and customer intelligence.

Mendel is a clinical AI platform for life sciences and healthcare organizations that deciphers health data with clinician-like logic. It indexes structured and unstructured data and replaces the complexity of querying with the simplicity of chatting.

BiomeSense, Inc. is a company that specializes in developing an integrated platform combining hardware, software, and data analytics to enhance the collection and analysis of microbiome data in clinical research. Founded in 2018 and based in Chicago, Illinois, BiomeSense has created the GutLab, an innovative "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology, along with the MetaBiome time-series analytics platform, provides a comprehensive solution that enables researchers, patients, and consumers to track microbiome changes in real time and understand their impact on health outcomes. By generating and analyzing large-scale, longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, ultimately improving precision medicine and the development of microbiome-based therapeutics and products.

Simbe Robotics, Inc. is a technology company based in San Francisco, California, specializing in autonomous robotic solutions for the retail industry. Founded in 2014, the company has developed a robotic system named Tally, which autonomously navigates store aisles to conduct shelf audits. Tally captures real-time inventory data, identifying out-of-stock items, low stock levels, misplaced products, and pricing discrepancies. By automating these repetitive and labor-intensive tasks, Simbe Robotics enhances operational efficiency for retail staff, allowing them to focus on customer service and other critical aspects of store management. The robotic system operates safely during regular store hours, effectively integrating into the shopping environment without disrupting customers or employees.

Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Pulse Industrial, founded in 2017 and based in California, specializes in developing advanced monitoring solutions for industrial plants, particularly focusing on steam systems. The company has created a smart steam trap monitoring device that employs artificial intelligence to detect steam leaks by analyzing vibration and acoustic behavior. This technology, known as QALM, enhances visibility into potential failures, alerting maintenance personnel through low power wide area communication. Additionally, Pulse Industrial is exploring thermal applications utilizing phase change materials, further expanding its innovative offerings in the industrial sector. By enabling remote monitoring of critical components like steam traps, the company aims to improve safety and reduce fuel consumption across various industrial processes.

Stae is a company focused on enhancing the capabilities of cities through a digital infrastructure platform that centralizes access to civic data. By partnering with local governments, Stae improves data-sharing workflows and enables better decision-making for city managers and workers. The platform integrates and manages diverse data sources, creating real-time feeds that allow for actionable insights. This approach not only supports compliance and procurement but also fosters innovation and performance within municipalities, ultimately giving cities a competitive edge in the management of their resources and services.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.

Chronus Health, Inc. is a company that specializes in developing a portable diagnostic platform aimed at delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and based in Mountain View, California, the company's innovative system utilizes microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time test results. This capability allows for immediate diagnosis at the point of care, enhancing the efficiency of treatment and significantly improving patient outcomes. By enabling doctors to obtain lab results in minutes, Chronus Health facilitates timely decision-making in clinical settings.

Wayfinder Biosciences is a biotechnology company based in Seattle, WA, focused on developing orally available small molecule drugs that target RNA to address key disease areas such as oncology and neurodegenerative disorders. Established in 2021, the company employs a proprietary platform that integrates advanced screening technologies and computational methods to efficiently discover potent and selective RNA-targeting molecules. By leveraging high-throughput screening combined with machine learning and unique datasets, Wayfinder aims to enable the development of drugs for traditionally inaccessible targets, thus addressing significant unmet medical needs in genetic diseases, cancer, and other conditions.

Journey Foods is a technology company that offers a machine learning-powered software platform tailored for the packaged food industry. It specializes in enhancing product monitoring and development for consumer packaged goods companies, ingredient suppliers, and manufacturers. The platform focuses on optimizing innovation, decision-making, and operational efficiency by providing insights into nutrition and supply chain dynamics. Journey Foods' software allows food companies to transform ideas into commercial products by configuring consumer preferences, generating improved product formulations, and offering automated compliance checks and sustainability metrics. With a robust database that includes over 1 billion ingredient insights, the platform utilizes advanced algorithms to deliver optimized portfolio recommendations based on pricing, supply chain, and nutritional considerations. By streamlining these processes, Journey Foods empowers management teams to make strategic decisions more swiftly, thereby facilitating greater efficiency in the $3 trillion packaged foods market.

Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.

Dalton Bioanalytics specializes in developing advanced analytical technology aimed at transforming blood analysis into a more efficient and cost-effective process. By digitizing the biochemical composition of blood, the company provides a comprehensive array of actionable health insights, addressing the limitations of traditional laboratory testing. This technology enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules, through a single assay. Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine. Founded in 2019, the company is headquartered in Los Angeles, California.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on the accelerated development of therapies utilizing small ribonucleic acid (RNA) and advanced bioinformatics. Founded in 2016, the company has developed a platform that employs artificial intelligence to identify error-free RNA biomarkers and discover disease-associated mutations. This platform enables precise classification of patient samples, which aids in the design of targeted therapeutics aimed at addressing various diseases, particularly in areas characterized by known heterogeneity such as fibrosis, inflammation, and neurodegeneration. By analyzing small RNA genes, Gatehouse Bio aims to unlock the potential for innovative treatments that could significantly enhance patient outcomes.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.

RxDiet is a developer of a nutritional guidance platform that leverages artificial intelligence and automation to provide personalized meal solutions and health interventions. The company partners with national food retailers and leading health plans to deliver fresh groceries tailored to individual cultural and lifestyle preferences. This approach not only promotes a balanced diet but also aims to achieve exceptional clinical outcomes and cost savings for users. By integrating "food as medicine" principles, RxDiet addresses the growing demand for effective nutritional support in healthcare.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Halla is a company that specializes in Taste Intelligence, focusing on delivering personalized grocery experiences through advanced artificial intelligence. Their platform combines food data and human behavior insights to create tailored product recommendations, substitutions, and search functionalities for grocery retailers. By utilizing machine learning models, Halla enables grocers to understand and respond to individual shopper preferences in real-time. The company's suite of products can be integrated into various customer touchpoints, including online cart pages and in-store promotions, enhancing customer engagement and driving sales. This approach not only helps shoppers discover appealing products at optimal moments but also aims to improve overall shopping experiences and increase transaction values.

Biomage is a company that focuses on single-cell analysis to advance life sciences research. It has developed a platform that transforms extensive single-cell sequencing data into meaningful biological insights, enabling researchers to conduct in-depth analyses with ease. This platform specifically caters to the needs of research biologists, facilitating the analysis of single-cell RNA sequencing. By streamlining the data interpretation process, Biomage enhances the potential for drug target discovery while significantly reducing costs. The company aims to empower scientists in both academia and industry, promoting the broader use of advanced sequencing technologies in various biological disciplines.

BiomeSense, Inc. is a company that specializes in developing an integrated platform combining hardware, software, and data analytics to enhance the collection and analysis of microbiome data in clinical research. Founded in 2018 and based in Chicago, Illinois, BiomeSense has created the GutLab, an innovative "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology, along with the MetaBiome time-series analytics platform, provides a comprehensive solution that enables researchers, patients, and consumers to track microbiome changes in real time and understand their impact on health outcomes. By generating and analyzing large-scale, longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, ultimately improving precision medicine and the development of microbiome-based therapeutics and products.

OncoPrecision is a company that focuses on improving cancer therapy outcomes by utilizing a patient micro avatar platform. This innovative platform employs single-cell high-throughput biology and machine learning to generate comprehensive patient-derived phenotypic biomarkers. By doing so, it enables oncologists to make informed, data-driven decisions regarding the selection of cancer therapies tailored to individual patients. The approach aims to increase the success rates of cancer treatments by ensuring that the right therapy is matched to the right patient, thus enhancing overall patient care and treatment effectiveness.

Mendel is a clinical AI platform for life sciences and healthcare organizations that deciphers health data with clinician-like logic. It indexes structured and unstructured data and replaces the complexity of querying with the simplicity of chatting.

Rosetta, Inc. operates as a SaaS platform that assists e-commerce sites in analyzing consumer preferences and enhancing customer retention. Founded in 2018 and based in Taipei, Taiwan, the company leverages deep learning technology to uncover individual consumer behaviors and predict future sales. By focusing on the fashion industry, including apparel, cosmetics, and accessories, Rosetta.ai develops specialized algorithms to cater to the distinct shopping preferences within this vertical. The platform provides personalized recommendations and tools designed to trigger consumer engagement, thereby helping e-commerce businesses improve conversion rates and increase order value, both online and offline.

Perimeter provides an AI-powered intruder detection system. It can detect an intruder before they enter the premises, and protect the outdoor. It was launched in 2020 and is based in Austin, Texas.

Halla is a company that specializes in Taste Intelligence, focusing on delivering personalized grocery experiences through advanced artificial intelligence. Their platform combines food data and human behavior insights to create tailored product recommendations, substitutions, and search functionalities for grocery retailers. By utilizing machine learning models, Halla enables grocers to understand and respond to individual shopper preferences in real-time. The company's suite of products can be integrated into various customer touchpoints, including online cart pages and in-store promotions, enhancing customer engagement and driving sales. This approach not only helps shoppers discover appealing products at optimal moments but also aims to improve overall shopping experiences and increase transaction values.

MikeLegal is Asia’s first Artificially Intelligent legal associate focused on streamlining the management of intellectual property tasks. Its software automates processes related to trademark public searches, journal monitoring, and portfolio management, allowing legal teams to reduce costs and enhance productivity. By leveraging real-time integration and a centralized cloud-based system, MikeLegal provides customizable solutions that keep information synchronized with registries and assists in the analysis of similar intellectual property marks. This enables law firms and corporations to make informed, data-driven legal decisions. The platform has been adopted by over 100 companies, including prominent firms such as Reliance Industries and Airtel, demonstrating its effectiveness in improving legal operations.

Pulse Industrial, founded in 2017 and based in California, specializes in developing advanced monitoring solutions for industrial plants, particularly focusing on steam systems. The company has created a smart steam trap monitoring device that employs artificial intelligence to detect steam leaks by analyzing vibration and acoustic behavior. This technology, known as QALM, enhances visibility into potential failures, alerting maintenance personnel through low power wide area communication. Additionally, Pulse Industrial is exploring thermal applications utilizing phase change materials, further expanding its innovative offerings in the industrial sector. By enabling remote monitoring of critical components like steam traps, the company aims to improve safety and reduce fuel consumption across various industrial processes.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Stae is a company focused on enhancing the capabilities of cities through a digital infrastructure platform that centralizes access to civic data. By partnering with local governments, Stae improves data-sharing workflows and enables better decision-making for city managers and workers. The platform integrates and manages diverse data sources, creating real-time feeds that allow for actionable insights. This approach not only supports compliance and procurement but also fosters innovation and performance within municipalities, ultimately giving cities a competitive edge in the management of their resources and services.

CITYDATA.ai is a developer of a geospatial artificial intelligence platform that simulates the presence and movement of people across 9,000 cities globally. The platform uses location intelligence to create mobility digital replicas, which quantify the number of people and their movement patterns in urban environments. CITYDATA.ai aggregates data from various public and private sources, facilitating insights into foot traffic and advertising effectiveness. It also offers a range of products, including CITYCOUNT.ai, CITYPARKS.ai, CITYFLOW.ai, CITYSIM.ai, CITYOPS.ai, CITYSURVEY.ai, CITYCHAT.ai, and CITYSDK.ai. These tools include mobile applications and chatbot solutions that engage residents with contextual information about their cities, enhance community involvement, and support on-site surveys and field workforce productivity.

Biomage is a company that focuses on single-cell analysis to advance life sciences research. It has developed a platform that transforms extensive single-cell sequencing data into meaningful biological insights, enabling researchers to conduct in-depth analyses with ease. This platform specifically caters to the needs of research biologists, facilitating the analysis of single-cell RNA sequencing. By streamlining the data interpretation process, Biomage enhances the potential for drug target discovery while significantly reducing costs. The company aims to empower scientists in both academia and industry, promoting the broader use of advanced sequencing technologies in various biological disciplines.

Dalton Bioanalytics specializes in developing advanced analytical technology aimed at transforming blood analysis into a more efficient and cost-effective process. By digitizing the biochemical composition of blood, the company provides a comprehensive array of actionable health insights, addressing the limitations of traditional laboratory testing. This technology enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules, through a single assay. Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine. Founded in 2019, the company is headquartered in Los Angeles, California.

Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Stae is a company focused on enhancing the capabilities of cities through a digital infrastructure platform that centralizes access to civic data. By partnering with local governments, Stae improves data-sharing workflows and enables better decision-making for city managers and workers. The platform integrates and manages diverse data sources, creating real-time feeds that allow for actionable insights. This approach not only supports compliance and procurement but also fosters innovation and performance within municipalities, ultimately giving cities a competitive edge in the management of their resources and services.

Symphony specializes in predictive maintenance solutions that leverage the Internet of Things and machine learning to enhance operational efficiency. The company has developed sensor devices that wirelessly monitor vibrations from machinery with moving components, transmitting data to the cloud for analysis. Unlike traditional preventative maintenance systems that rely on technicians to interpret raw data, Symphony's approach simplifies the process by delivering actionable alerts directly to facility managers. This allows for quick identification of potential machinery problems, ultimately reducing unscheduled downtime and unnecessary planned maintenance. Facilities can implement Symphony's solution with a modest investment, which is designed to yield significant returns. Once the initial benefits are realized, the system can be easily scaled to monitor additional machines through the installation of more sensors and associated software licenses. By focusing on training AI algorithms rather than human operators, Symphony provides managers with the tools to effectively track machine performance over time, ensuring the smooth operation of industrial processes.

Rosetta, Inc. operates as a SaaS platform that assists e-commerce sites in analyzing consumer preferences and enhancing customer retention. Founded in 2018 and based in Taipei, Taiwan, the company leverages deep learning technology to uncover individual consumer behaviors and predict future sales. By focusing on the fashion industry, including apparel, cosmetics, and accessories, Rosetta.ai develops specialized algorithms to cater to the distinct shopping preferences within this vertical. The platform provides personalized recommendations and tools designed to trigger consumer engagement, thereby helping e-commerce businesses improve conversion rates and increase order value, both online and offline.

sRNAlytics developed a computational platform to diagnose and subtype disease using small RNAs. We offer our technology and services to drug developers to identify companion diagnostics and uncover new therapeutic targets.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.

Chronus Health, Inc. is a company that specializes in developing a portable diagnostic platform aimed at delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and based in Mountain View, California, the company's innovative system utilizes microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time test results. This capability allows for immediate diagnosis at the point of care, enhancing the efficiency of treatment and significantly improving patient outcomes. By enabling doctors to obtain lab results in minutes, Chronus Health facilitates timely decision-making in clinical settings.

The Futures Agency helps companies, organizations and individuals to better understand.

VIT Initiative, Inc. is a health and safety company based in San Francisco, California, that develops a cloud-enabled Internet of Things (IoT) platform aimed at reducing operational risks and promoting employee health. Founded in 2015, the company focuses on utilizing smart technology to provide real-time coaching and collect data on leading indicators of workplace injuries. This approach helps businesses mitigate risks, enhance operational efficiency, and improve safety compliance, ultimately leading to reduced cycle times and lower injury-related costs. Additionally, VIT Initiative offers automated COVID-19 symptom tracking, further supporting workplace health initiatives. Their products are designed to identify patterns and behaviors that may lead to health problems, allowing for proactive intervention before complications arise.

Esports Charts is a global analytical platform that enhances the understanding of the esports industry by providing transparent and reliable viewership data. It offers four interconnected services designed to assist gamers, businesses, streamers, and advertisers in navigating the esports landscape. The platform collects and analyzes data from various broadcasting sources, focusing on key metrics for channels, streams, and communities. By utilizing extensive historical data, Esports Charts can predict future viewership trends and track performance for esports partnerships. This functionality enables sponsors, organizers, and viewers to assess the popularity of broadcasts and events easily, fostering greater trust and engagement in the esports ecosystem.

The Futures Agency helps companies, organizations and individuals to better understand.

Journey Foods is a technology company that offers a machine learning-powered software platform tailored for the packaged food industry. It specializes in enhancing product monitoring and development for consumer packaged goods companies, ingredient suppliers, and manufacturers. The platform focuses on optimizing innovation, decision-making, and operational efficiency by providing insights into nutrition and supply chain dynamics. Journey Foods' software allows food companies to transform ideas into commercial products by configuring consumer preferences, generating improved product formulations, and offering automated compliance checks and sustainability metrics. With a robust database that includes over 1 billion ingredient insights, the platform utilizes advanced algorithms to deliver optimized portfolio recommendations based on pricing, supply chain, and nutritional considerations. By streamlining these processes, Journey Foods empowers management teams to make strategic decisions more swiftly, thereby facilitating greater efficiency in the $3 trillion packaged foods market.

Stae is a company focused on enhancing the capabilities of cities through a digital infrastructure platform that centralizes access to civic data. By partnering with local governments, Stae improves data-sharing workflows and enables better decision-making for city managers and workers. The platform integrates and manages diverse data sources, creating real-time feeds that allow for actionable insights. This approach not only supports compliance and procurement but also fosters innovation and performance within municipalities, ultimately giving cities a competitive edge in the management of their resources and services.

Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.

Amper Technologies, Inc. is a Chicago-based company founded in 2016 that develops a clip-on device designed to help factory owners and managers analyze power consumption, predict machine downtime, and implement predictive maintenance. The company provides a comprehensive solution that includes both hardware and software, featuring non-invasive sensors, an Internet-connected gateway, and web dashboards. This technology enables plant managers to monitor various machine types, thereby enhancing productivity and overall equipment effectiveness (OEE). Amper's real-time monitoring and analytics tools allow manufacturing teams to identify root causes of issues, optimize operations, and reduce production losses. The solution is user-friendly and can be deployed quickly across different machines, empowering operators and managers with actionable data to improve performance and meet production targets.

BiomeSense, Inc. is a company that specializes in developing an integrated platform combining hardware, software, and data analytics to enhance the collection and analysis of microbiome data in clinical research. Founded in 2018 and based in Chicago, Illinois, BiomeSense has created the GutLab, an innovative "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology, along with the MetaBiome time-series analytics platform, provides a comprehensive solution that enables researchers, patients, and consumers to track microbiome changes in real time and understand their impact on health outcomes. By generating and analyzing large-scale, longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, ultimately improving precision medicine and the development of microbiome-based therapeutics and products.

AI Nutrition develops an AI that automates online grocery shopping and precision nutrition for better health outcomes.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.